Additionally, the MORC2 promoter methylation was markedly increased in CRC tissues (P < 0.05), but the methylation of MORC1, MORC3, and MORC4 was significantly lower in the tumor tissues than in negative controls (Fig. 7b). The gene discussed is MORC2; the disease is colorectal carcinoma.